Amphastar Pharmaceuticals, Inc. AMPH

Set alert

Price alert · AMPH

All alert types
27.10 USD +0.07 +0.24%

As of Nov 3, 1:09 PM ET

Bid
27.07 × 2
Ask
27.10 × 2
26.85 Day range 27.29
16.65 52-week range 29.52
YTD
+1.18%
1 year
+7.10%
Open
27.04
Prev close
27.03
Mkt cap
1.15B
Vol
102.98K
Avg vol
467.31K
EPS
1.69
P/E
16.02
Div yield
0.00%
More statistics
Low
26.85
High
27.29
Forward P/E
8.52
Beta
0.94
Short ratio
8.22
Inst. own
68.48%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
24.76
200-d avg
22.25
1y target
22.50

5D chart

Chart tools
Interval

Signals (108)
NameTimeAgo
SMA: BullishOct 30, 3:35 PM3 days ago
SMA: BullishOct 30, 3:30 PM3 days ago
MACD: Buy SignalOct 30, 3:30 PM3 days ago
SMA: BearishOct 30, 3:20 PM3 days ago
SMA: BullishOct 30, 3:10 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
SMA: BearishOct 30, 2:10 PM3 days ago
SMA: BullishOct 30, 1:45 PM4 days ago
SMA: BullishOct 30, 1:45 PM4 days ago
SMA: BearishOct 30, 1:40 PM4 days ago
SMA: BearishOct 30, 1:00 PM4 days ago
SMA: BullishOct 30, 12:55 PM4 days ago
SMA: BearishOct 30, 12:50 PM4 days ago
MACD: Sell SignalOct 30, 12:50 PM4 days ago
RSI: OverboughtOct 30, 11:50 AM4 days ago
RSI: OverboughtOct 30, 11:35 AM4 days ago
MACD: Buy SignalOct 30, 11:10 AM4 days ago
SMA: BullishOct 30, 11:05 AM4 days ago
SMA: BullishOct 30, 10:50 AM4 days ago
SMA: BearishOct 30, 10:05 AM4 days ago

Newest 20 of 108.

Analyst view

Consensus: hold

Hold
Price target (mean) 22.50 -17.0% downside
Target (low)
20.00
Target (mean)
22.50
Target (high)
30.00
Ratings (0m) 7 0 buy · 6 hold · 1 sell
  • Strong buy0
  • Buy0
  • Hold6
  • Sell0
  • Strong sell1

Recommendation trend

  • This month 7
  • 1 month ago 7
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

AMPH analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.858670.70 – 1.050.93-7.7%197.50M+3.0%7
Next quarter0.690.69 – 0.690.51+35.3%194.77M+6.4%1
Current year2.962.59 – 3.243.25-8.9%747.32M+3.8%7
Next year2.642.64 – 2.642.17+21.7%783.99M+4.9%1

Upgrades and downgrades

The latest rating changes

AMPH analyst upgrades and downgrades
DateFirmActionFromTo
Aug 18, 2026BarclaysMaintainedEqual-WeightEqual-Weight
Aug 7, 2026Piper SandlerMaintainedNeutralNeutral
Aug 7, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Jun 29, 2026B of A SecuritiesDowngradeNeutralUnderperform
Jun 3, 2026BarclaysMaintainedEqual-WeightEqual-Weight
May 14, 2026Wells FargoDowngradeOverweightEqual-Weight
May 11, 2026Piper SandlerReiteratedNeutralNeutral
May 8, 2026NeedhamDowngradeBuyHold
Apr 21, 2026JefferiesDowngradeBuyHold
Apr 8, 2026BarclaysMaintainedEqual-WeightEqual-Weight
Feb 27, 2026Wells FargoMaintainedOverweightOverweight
Feb 27, 2026NeedhamMaintainedBuyBuy
Dec 9, 2025BarclaysInitiated—Equal-Weight
Nov 7, 2025NeedhamMaintainedBuyBuy
Oct 22, 2025NeedhamReiteratedBuyBuy
Aug 26, 2025B of A SecuritiesMaintainedNeutralNeutral
Aug 12, 2025NeedhamUpgradeHoldBuy
Aug 8, 2025Piper SandlerMaintainedNeutralNeutral
May 12, 2025JP MorganDowngradeOverweightNeutral
May 8, 2025Wells FargoMaintainedOverweightOverweight
Apr 10, 2025NeedhamReiteratedHoldHold
Mar 21, 2025Piper SandlerMaintainedNeutralNeutral
Feb 4, 2025Piper SandlerDowngradeOverweightNeutral
Nov 22, 2024Wells FargoInitiated—Overweight
Aug 8, 2024NeedhamReiterated—Hold
Aug 8, 2024Piper SandlerMaintainedOverweightOverweight
Jun 27, 2024Piper SandlerReiteratedOverweightOverweight
May 22, 2024NeedhamReiterated—Hold
May 9, 2024NeedhamReiterated—Hold
Apr 10, 2024NeedhamReiterated—Hold